145 related articles for article (PubMed ID: 10338388)
1. Mesalamine: safe at first look.
Saubermann LJ; Wolf JL
Inflamm Bowel Dis; 1999 May; 5(2):148-9. PubMed ID: 10338388
[No Abstract] [Full Text] [Related]
2. Safety of high doses of mesalazine during pregnancy.
Marteau P; Seksik P; Couve S; Jian R
Am J Gastroenterol; 2005 Aug; 100(8):1897-8. PubMed ID: 16086733
[No Abstract] [Full Text] [Related]
3. The safety of mesalamine in human pregnancy: a prospective controlled cohort study.
Diav-Citrin O; Park YH; Veerasuntharam G; Polachek H; Bologa M; Pastuszak A; Koren G
Gastroenterology; 1998 Jan; 114(1):23-8. PubMed ID: 9428214
[TBL] [Abstract][Full Text] [Related]
4. Which are the 5-ASA compound side effects and how is it possible to avoid them?
Moum B
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S212-3. PubMed ID: 18816767
[No Abstract] [Full Text] [Related]
5. Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report.
Kohli R; Melin-Aldana H; Sentongo TA
J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):479-82. PubMed ID: 16205520
[No Abstract] [Full Text] [Related]
6. Hypereosinophilia due to mesalazine treatment.
Usta Y; Ozen H; Gurakan F; Uslu N; Saltik-Temizel IN; Demir H; Yuce A
J Clin Gastroenterol; 2009 Apr; 43(4):382. PubMed ID: 19309777
[No Abstract] [Full Text] [Related]
7. Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease.
Druez A; Rahier JF; Hébuterne X
J Crohns Colitis; 2014 Aug; 8(8):900-1. PubMed ID: 24486176
[No Abstract] [Full Text] [Related]
8. Massive pericardial effusion in a child following the administration of mesalamine.
Kaiser GC; Milov DE; Erhart NA; Bailey DJ
J Pediatr Gastroenterol Nutr; 1997 Oct; 25(4):435-8. PubMed ID: 9327378
[No Abstract] [Full Text] [Related]
9. Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight.
Sachar D
Gut; 1998 Sep; 43(3):316. PubMed ID: 9863473
[No Abstract] [Full Text] [Related]
10. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?
De Broe ME; Stolear JC; Nouwen EJ; Elseviers MM
Nephrol Dial Transplant; 1997 Sep; 12(9):1839-41. PubMed ID: 9306332
[No Abstract] [Full Text] [Related]
11. [Pregnancy outcome in inflammatory bowel diseases].
Tennenbaum R; Marteau P; Elefant E; Rambaud JC; Modigliani R; Gendre JP; Cosnes J
Gastroenterol Clin Biol; 1999 May; 23(5):464-9. PubMed ID: 10429848
[TBL] [Abstract][Full Text] [Related]
12. Reproductive issues in inflammatory bowel disease.
Saha S; Esposti SD
Med Health R I; 2009 Apr; 92(4):148-51. PubMed ID: 19452759
[No Abstract] [Full Text] [Related]
13. Management of inflammatory bowel disease during pregnancy and nursing.
Friedman S
Semin Gastrointest Dis; 2001 Oct; 12(4):245-52. PubMed ID: 11726078
[TBL] [Abstract][Full Text] [Related]
14. Mesalazine is safe for the treatment of IBD.
D'Haens G; van Bodegraven AA
Gut; 2004 Jan; 53(1):155. PubMed ID: 14684596
[No Abstract] [Full Text] [Related]
15. Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
Iofel E; Chawla A; Daum F; Markowitz J
J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):73-6. PubMed ID: 11753169
[No Abstract] [Full Text] [Related]
16. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules.
Marteau P; Tennenbaum R; Elefant E; Lémann M; Cosnes J
Aliment Pharmacol Ther; 1998 Nov; 12(11):1101-8. PubMed ID: 9845399
[TBL] [Abstract][Full Text] [Related]
17. Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease.
Goldstein F; DiMarino AJ
J Clin Gastroenterol; 2000 Jul; 31(1):60-2. PubMed ID: 10914779
[TBL] [Abstract][Full Text] [Related]
18. How safe are the safest IBD drugs?
Lewis JD
Gastroenterology; 2003 Jun; 124(7):1986-7; discussion 1987-8. PubMed ID: 12806636
[No Abstract] [Full Text] [Related]
19. Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine.
Skhiri H; Knebelmann B; Martin-Lefevre L; Grunfeld JP
Nephron; 1998; 79(2):236. PubMed ID: 9647514
[No Abstract] [Full Text] [Related]
20. [Commentaries on the article "are there frequent errors in the management of outpatients with inflammatory bowel disease?"].
Sánchez-Muñoz D; Castro-Fernández M
Gastroenterol Hepatol; 2008 Apr; 31(4):265. PubMed ID: 18405494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
